Publication | Closed Access

Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)

Respiratory Syncytial VirusNeurovirologyPharmacologyAntiviral ResponseNovel RnaiVirologyAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyAntiviral DrugMedicineAntiviral Compound